Nikolić, Katarina

Type

Date issued

372 2000 - 2027
32 1000 - 1999

Mp-cat.

214 М30/М60
58 M21
36 M22
29 M23
24 M21a
20 M20/M50
8 M21a+
5 M53
5 other
3 M52
. next >

Date issued - custom

Year from:

Year to:

Results 141-160 of 404 Results/Page

Issue Date	Title	Author(s)	Type	Мp-cat.
2020	Chemometrically Assisted RP-HPLC Method Development for Efficient Separation of Ivabradine and its Eleven Impurities	Tomić, Jovana; Ivković, Branka ; Oljačić, Slavica ; Nikolić, Katarina ; Maljurić, Nevena ; Protić, Ana ; Agbaba, Danica	Article	23M23
2020	Combined ligand-based and structure-based approaches in rational drug design of novel 5-HT2A receptor antagonists	Radan, Milica M. ; Ružić, Dušan B. ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2019	The SF5 moiety as promising substituent for the design of novel D2 and D3 receptors ligands	Elek, Milica; Frank, Annika; Đoković, Nemanja ; Oljačić, Slavica ; Živković, Aleksandra; Nikolić, Katarina ; Stark, Holger	Conference Paper	Mp. category will be shown later
2019	Severe hepatotoxicity induced by efavirenz in a treatment-naïve, low body mass index HIV-infected, female patient with no hepatitis and other virus co-infections	Dragović-Lukić, Gordana ; Nikolić, Katarina ; Dimitrijević, Božana ; Jevtović, Đorđe ; Salemović, Dubravka; Tomanović, Nada ; Boričić, Ivan	Article	23M23
2019	Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches	Vucicevic, Jelica; Nikolić, Katarina ; Mitchell, John B.O.	Article	21M21
2019	Is there a borderline between cytotoxic and antimetastatic effects of selective Histone deacetylase 6 inhibitors in solid malignancies?	Nikolić, Katarina M. ; Ružić, Dušan B. ; Milan Beljkas ; Petković, Miloš R. ; Sheraz Gul; Juan F. Santibanez; Srdić-Rajić, Tatjana V.	Conference Paper	Mp. category will be shown later
2019	Structure and ligand based drug design strategies in the development of novel serotonin 5-HT2A receptor antagonists	Radan, Milica M. ; Mirjana Antonijevic; Ružić, Dušan B. ; Đikić, Teodora M. ; Danica Agbaba; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2019	Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase-6 Inhibitors	Ružić, Dušan ; Petković, Miloš ; Agbaba, Danica ; Ganesan, A.; Nikolić, Katarina	Article	21M21
2019	Development and Screening of Novel Chemical Probes Targeting Histone Methyltransferase	Si, Yang; Bon, Corentin; Ružić, Dušan ; Nikolić, Katarina ; Agou, Fabrice; Halby, Ludovic; Arimondo, Paola	Conference Paper	Mp. category will be shown later
2019	Structure-Based Design of Selective Histone Deacetylase 6 Zinc Binding Groups	Alves, Avelar Leandro A.; Ružić, Dušan ; Đoković, Nemanja ; Kurz, Thomas; Nikolić, Katarina	Article	21M21
2019	Combined 3D-QSAR modeling, molecular dynamics and molecular docking studies in rational drug design of novel 5-HT2A antagonists	Radan, Milica M. ; Mirjana Antonijevic; Đikić, Teodora M. ; Ružić, Dušan B. ; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2019	Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets	Stevanović, Strahinja; Senćanski, Milan ; Danel, Mathieu; Menendez, Christophe; Belguedj, Roumaissa; Bouraiou, Abdelmalek; Nikolić, Katarina M. ; Cojean, Sandrine; Loiseau, Philippe Marie; Glišić, Sanja ; Baltas, Michel; García-Sosa, Alfonso;	Article	21M21
2019	Rational design of multi-target compounds with potential anticancer activity	Dobričić, Vladimir D. ; Olujić, Jelena; Nikolić, Katarina ; Vučićević, Jelica; Gagić, Žarko ; Filipić, Slavica ; Agbaba, Danica ; Čudina, Olivera	Conference Paper	Mp. category will be shown later
2019	Pentafluorosulfanyl (SF5) moiety as promising substituent in synthesis and design of novel D2 and D3 receptors ligands	Milica Elek; Annika Frank; Đoković, Nemanja B. ; Slavica Oljacic; Aleksandra Zivkovic; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2019	3D-QSAR studies and design of selective PI3K-α kinase inhibitors as potential antineoplastics	M. Jovanovic ; Z. Gagic; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2019	Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling	Bouchet, Samuel; Linot, Camille; Ružić, Dušan ; Agbaba, Danica ; Fouchaq, Benoit; Roche, Joelle; Nikolić, Katarina ; Blanquart, Christophe; Bertrand, Philippe	Article	21M21
2019	Preclinical data on (2-imidazolin-4-yl) phosphonates	Nikolić, Katarina M. ; Radan, Milica M. ; Đikić, Teodora M. ; S. Rodríguez-Arévalo; A. Bagán; P. Pérez-Lozano; F. Vasilopoulou; C. Griñán-Ferré; M. Pallàs; B. Pérez; L. F. Callado; E. Hernández; J. M. García-Fuster; J. A. García-Sevilla; J. Brea; M. I. Loza; L. Naesens; C. Escolano;	Conference Paper	Mp. category will be shown later
2019	Structure and ligand based drug design strategies in the development of novel serotonin 5-HTt2a receptor antagonists	Radan, Milica ; Antonijević, Mirjana; Ružić, Dušan ; Đikić, Teodora ; Agbaba, Danica ; Nikolić, Katarina	Conference Paper	Mp. category will be shown later
2019	Rational drug design of novel 5-HT2A antagonists	Radan, Milica M. ; Đikić, Teodora M. ; Ružić, Dušan B. ; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2019	Development and Screening of Novel Chemical Probes Targeting Histone Methyltransferases	Yang Si; Corentin Bon; Ružić, Dušan B. ; Nikolić, Katarina M. ; Fabrice Agou; Ludovic Halby; Paola Arimondo	Conference Paper	Mp. category will be shown later